The implementation of selective NCLX ligands, instead of the so-called promiscuous drugs such as CGP37157, in animal models of ND should help to obtain an agreement on the role of NCLX in both physiological and pathological scenarios. This evidence concerns the gene SLC8B1 and Norrie disease.